External composition
The combination of ascorbic acid and Magnolia extracts with Prunus extracts, along with specific additives, addresses the inadequacies of conventional skin whitening products by dramatically improving melanin inhibition and cosmetic benefits.
Patent Information
- Application Number
- JP2020168848
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2020-10-06
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2035-09-30
AI Technical Summary
Conventional skin whitening compositions using ascorbic acid and plant extracts do not fully satisfy consumer demands for effective melanin suppression and provide insufficient cosmetic benefits.
A combination of ascorbic acid and/or its derivatives with Magnolia genus extracts from the Magnoliaceae family, optionally combined with Prunus genus extracts from the Rosaceae family, along with a water-soluble thickener, porous powder, and trimethylglycine, to enhance melanin inhibition and improve application feel.
The composition significantly inhibits melanin production, providing superior whitening effects while offering a firm application feel, reducing stickiness, suppressing powderiness, and enhancing moisturization.
Smart Images

Figure 0007577499000001 
Figure 0007577499000002 
Figure 0007577499000003
Abstract
Description
[Technical field]
[0001] The present invention relates to a composition for external use that inhibits melanin production and exhibits excellent whitening effects. [Background technology]
[0002] It is known that skin pigmentation such as age spots, freckles, dullness, dark spots, liver spots, and senile pigmentation occurs when melanin is excessively formed and deposited in the skin due to exposure to ultraviolet light, hormonal abnormalities, physical stimuli, etc. Such skin pigmentation is a major cosmetic concern, especially for women.
[0003] Conventionally, ascorbic acid and its derivatives have been known to suppress skin pigmentation and exhibit whitening effects, and have been widely used in topical whitening compositions. However, the whitening effects of ascorbic acid and its derivatives do not fully satisfy consumer needs.
[0004] In addition, some plant extracts are known to have cosmetic effects. For example, Patent Document 1 reports that Magnolia extract has an effect of inhibiting collagenase activity and is effective in preventing skin aging. In addition, Patent Document 2 reports that an enzymatic hydrolysis product of prunes has an effect of suppressing phagocytosis, suppressing the migration of melanin pigment to the body surface, and exerts a whitening effect. However, the cosmetic effects exerted by the plant extract alone are slow, and have the disadvantage of not being able to fully satisfy consumer needs.
[0005] Consumer demand for skin whitening is increasing year by year, and the whitening effect obtained by conventional formulation techniques is no longer sufficient to satisfy consumer demand. Therefore, in order to meet the ever-increasing demands of consumers in the future, it is desired to develop a topical composition that has a more excellent whitening effect. [Prior art documents] [Patent documents]
[0006] [Patent Document 1] JP 2003-146876 A [Patent Document 2] JP 2006-347926 A Summary of the Invention [Problem to be solved by the invention]
[0007] An object of the present invention is to provide a composition for external use that effectively inhibits melanin production, thereby exerting an excellent whitening effect. [Means for solving the problem]
[0008] The present inventors have conducted extensive research to solve the above problems and have found that the combined use of ascorbic acid and / or a derivative thereof with an extract of a plant of the genus Magnolia in the family Magnoliaceae dramatically increases the melanin production inhibitory effect, resulting in a significantly superior whitening effect. Furthermore, the inventors have found that the whitening effect is further improved by combining the above two components with an extract of a plant of the genus Prunus in the family Rosaceae.
[0009] Furthermore, it has been found that by formulating the above-mentioned components together with a water-soluble thickener, a porous powder, and trimethylglycine, an excellent whitening effect is exhibited, and at the time of application, the composition has a firm feel while being less sticky and has a refreshing feel, and after application, the composition is less powdery and provides an excellent moisturizing feel.
[0010] The present invention has been completed based on these findings and through further investigations. That is, the present invention provides the following aspects. Item 1. A composition for external use comprising (A) ascorbic acid and / or a derivative thereof, and (B) an extract of a plant of the genus Magnolia in the family Magnoliaceae. Item 2. The composition for external use according to Item 1, further comprising (C) an extract of a plant of the genus Prunus in the family Rosaceae. Item 3. The composition for external use according to Item 1 or 2, wherein the component (B) is an extract of Magnolia obovata. Item 4. The topical composition according to any one of Items 1 to 3, wherein the component (C) is an extract of prune. Composition. Item 5. The composition according to any one of Items 1 to 4, wherein the component (A) is ascorbic acid 2-glucoside. The composition for topical use described above. Item 6. The composition for external use according to any one of Items 1 to 5, which is used for whitening. Effect of the Invention
[0011] The topical composition of the present invention has a high melanin production inhibitory effect, and can effectively prevent or improve pigmentation such as skin blemishes, freckles, dullness, dark spots, liver spots, senile pigmentation, etc. In addition, one embodiment of the topical composition of the present invention has a firm application feel while suppressing stickiness and providing a refreshing feel, and after application, the powdery feeling is suppressed, and an excellent moisturizing feel is obtained, so that the composition can also have a good usability. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0012] The topical composition of the present invention is characterized by containing ascorbic acid and / or a derivative thereof (sometimes referred to as component (A)) and an extract of a plant of the genus Magnolia in the family Magnoliaceae (sometimes referred to as component (B)). The topical composition of the present invention will be described in detail below.
[0013] (A) Ascorbic acid and / or its derivatives The composition for external use of the present invention contains ascorbic acid and / or a derivative thereof. Ascorbic acid and / or a derivative thereof are known ingredients that have antioxidant properties and are known to have whitening effects.
[0014] The ascorbic acid and its derivatives used in the present invention are not particularly limited as long as they are pharma- ceutically or cosmetically acceptable, and examples thereof include ascorbic acid; ascorbic acid 2-glucoside; ascorbic acid monoalkyl esters such as ascorbic acid monostearate, ascorbic acid monopalmitate, and ascorbic acid monooleate; ascorbic acid monoesters such as ascorbic acid monophosphate and its magnesium salt; ascorbic acid dialkyl esters such as ascorbic acid distearate, ascorbic acid dipalmitate, and ascorbic acid dioleate; ascorbic acid diphosphate and its Examples of ascorbic acid diesters include ascorbic acid diesters such as salts; trialkyl esters such as ascorbic acid tristearate, ascorbic acid tripalmitate, and ascorbic acid trioleate; ascorbic acid triesters such as ascorbic acid triphosphate; 3-O-ethyl, 6-acetyl-ascorbic acid, 3-O-ethyl, 6-butyl ascorbic acid, 3-O-ethyl, 6-lauroyl ascorbic acid, 3-O-ethyl, 6-palmitoyl ascorbic acid, 3-O-ethyl, 6-oleoyl ascorbic acid, 3-O-ethyl, 6-stearoyl ascorbic acid, and 3-O-ethyl, 6-beherminoyl ascorbic acid. These ascorbic acids and derivatives thereof may be either the L-form or the D-form, and preferably the L-form.
[0015] These ascorbic acid and its derivatives may be used alone or in combination of two or more. Among these ascorbic acid and its derivatives, from the viewpoints of stability, whitening effect, etc., preferred are ascorbic acid derivatives, more preferred is ascorbic acid 2-glucoside.
[0016] The content of component (A) in the topical composition of the present invention may be appropriately set depending on the formulation form of the topical composition, and may be, for example, 0.1 to 10% by weight, preferably 0.3 to 8% by weight, and more preferably 0.5 to 7% by weight.
[0017] (B) Extract of Magnolia genus plant from the Magnoliaceae family The composition for external use of the present invention contains an extract of a plant of the genus Magnolia in the family Magnoliaceae together with ascorbic acid and / or a derivative thereof. By using ascorbic acid and / or a derivative thereof in combination with an extract of a plant of the genus Magnoliaceae in the family Magnoliaceae, the melanin production inhibitory effect is dramatically increased, and it is possible to achieve a significantly superior whitening effect.
[0018] The extract of a plant of the genus Magnolia of the family Magnoliaceae can be obtained by carrying out a solvent extraction treatment using a plant of the genus Magnoliaceae of the family Magnoliaceae as an extraction raw material.
[0019] The Magnoliaceae Magnolia genus plants used as the extraction raw material include those listed in "The World Plants in Color Encyclopedia" (first published on April 20, 1986, Hokuryukan Co., Ltd.), and specifically include Magnolia biloba, Boshunka, White Magnolia, Magnolia kobus (Magnolia magnoliaceae, Magnolia kobus, Magnolia japonica), Magnolia sieboldii (Magnolia chinensis), Magnolia sprengeri, Magnolia obovata (Magnolia chinensis, Magnolia chinensis, Magnolia sieboldii), and the like. Among these extraction raw material plants, one plant may be used alone, or two or more plants may be used in combination. Among these extraction raw materials, Magnolia obovata is preferred from the viewpoint of achieving a more excellent whitening effect.
[0020] The extract of a plant of the genus Magnolia in the family Magnoliaceae may be extracted from the bark of the plant, but the parts to be extracted may include, in addition to the bark, flowers, inflorescences, pericarp, fruit, stems, leaves, branches, foliage, trunks, rhizomes, roots, seeds, etc., as necessary, and may even be the whole tree.
[0021] Examples of extraction solvents used in the solvent extraction treatment of Magnoliaceae plants include water, lower alcohols having 1 to 5 carbon atoms such as methanol, ethanol, propanol, isopropyl alcohol, butanol, and isobutanol, polyhydric alcohols such as propylene glycol, 1,3-butylene glycol, and glycerin, and mixtures thereof. Among these extraction solvents, preferred are water, mixtures of lower alcohols having 1 to 5 carbon atoms and water, and mixtures of polyhydric alcohols and water, and more preferred are water, mixtures of ethanol and water, mixtures of 1,3-butylene glycol and water, and mixtures of propylene glycol and water.
[0022] When a mixture of a lower alcohol and / or a polyhydric alcohol having 1 to 5 carbon atoms and water is used as the extraction solvent, the concentration of the lower alcohol and / or the polyhydric alcohol having 1 to 5 carbon atoms is not particularly limited, but may be, for example, 20 to 90% by weight, preferably 30 to 85% by weight, in total.
[0023] The extract of a plant of the genus Magnolia in the family Magnoliaceae can be obtained by extracting the above-mentioned plant part to be extracted with the above-mentioned extraction solvent, either directly or after drying, shredding, crushing, squeezing, enzymatic treatment, boiling or fermentation, as necessary. As the solvent extraction treatment, any commonly used method for extracting plant extracts can be used, and specific examples include a soaking method such as cold soaking or hot soaking, a method of stirring under heating, or a percolation method.
[0024] The extract obtained by the solvent extraction treatment may be used in a liquid state as it is, or may be used as a concentrate or a dry product after being subjected to a treatment such as concentration or drying, if necessary. After concentration or drying, the concentrate or dry product may be purified by washing with a non-soluble solvent before use, or may be dissolved or suspended in a suitable solvent before use.
[0025] In addition, commercially available extracts of plants of the genus Magnolia and the family Magnoliaceae can be used easily. For example, extracts of the bark of Magnolia obovata include "Falcorex Magnolia B" and "Falcorex Magnolia E" manufactured by Ichimaru Falcos Co., Ltd.
[0026] The content of the (B) component in the topical composition of the present invention may be appropriately set depending on the formulation form of the topical composition, and is, for example, 0.00001% by weight or more, specifically 0.00001 to 0.1% by weight, calculated as the dry weight of the (B) component. From the viewpoint of achieving a more excellent whitening effect, the content of the (B) component in the topical composition of the present invention is preferably 0.00005 to 0.05% by weight, more preferably 0.0001 to 0.01% by weight, calculated as the dry weight of the (B) component.
[0027] In the topical composition of the present invention, the ratio of component (A) to component (B) is determined according to the respective contents described above. From the viewpoint of achieving an even more excellent whitening effect, the amount of component (B) per 100 parts by weight of component (A), calculated as the dry weight, is 0.001 part by weight or more, preferably 0.001 to 1 part by weight, more preferably 0.005 to 0.5 parts by weight, and even more preferably 0.01 to 0.1 part by weight.
[0028] (C) Extract of Prunus genus plant from the Rosaceae family The topical composition of the present invention may contain an extract of a plant of the genus Prunus of the family Rosaceae (sometimes referred to as component (C)) in addition to components (A) and (B). When an extract of a plant of the genus Prunus of the family Rosaceae is contained together with components (A) and (B), the whitening effect can be further improved.
[0029] The extract of a plant of the genus Prunus of the family Rosaceae can be obtained by carrying out a solvent extraction treatment using a plant of the genus Prunus of the family Rosaceae as an extraction raw material.
[0030] The Rosaceae Prunus genus plants used as the raw material for extraction include those listed in the "Color World Plant Encyclopedia" (first published April 20, 1986, Hokuryukan Co., Ltd.), and more specifically, these include plum (Prunus domestica), apricot (April 1900), Prunus conradinae, Japanese snow cherry (Prunus keyana), clove cherry (Prunus cuneata), dog cherry (Prunus arbutus), Japanese snow cherry (Prunus japonica), wild cherry (Prunus yamazakura), mamezakura (Prunus fujizakura), weeping cherry (Prunus itozaku), and more. Examples of the raw materials for extraction include: Japanese plum (Koume, Linshobai), Kanzan (Sekiyama), Oshimazakura, Miyamazakura, Ume, Minezakura, Bungoume, Chishimazakura, Peach, Edohigan (Ubahigan), Plum (Hatankyo), Oyamazakura, Linboku (Hiragigashi), Shiorizakura (Miyamainuzakura, Shiorizakura), Higanzakura (Kohiganzakura), Someiyoshino, Bakuchinoki (Biran, Biranju), etc. Among these raw materials for extraction, one type of plant may be used alone, or two or more types of plants may be used in combination. Among these raw materials for extraction, prunes are preferably used from the viewpoint of further enhancing the whitening effect.
[0031] The extract of a plant of the genus Prunus in the family Rosaceae may be extracted from the pulp of the plant, but the plant parts to be extracted may include the skin, seeds, etc., as well as the pulp, as necessary.
[0032] Examples of the extraction solvent used in the solvent extraction treatment of the Rosaceae Prunus plant include water; lower alcohols having 1 to 5 carbon atoms, such as methanol, ethanol, propanol, isopropyl alcohol, butanol, and isobutanol; polyhydric alcohols, such as propylene glycol, 1,3-butylene glycol, 1,2-butylene glycol, 1,4-butylene glycol, 1,5-pentanediol, 1,2-pentanediol, 1,3-pentanediol, 1,4-pentanediol, and 1,3,5-pentanetriol; phenoxyethanol, paraben, ethylparaben, methylparaben, propylparaben; and mixtures thereof. Among these extraction solvents, preferred are water, a mixture of polyhydric alcohol and water, and a mixture of lower alcohol having 1 to 5 carbon atoms and water, and more preferred are water and a mixture of 1,3-butylene glycol and water.
[0033] When a mixture of a lower alcohol and / or a polyhydric alcohol having 1 to 5 carbon atoms and water is used as the extraction solvent, the concentration of the lower alcohol and / or the polyhydric alcohol having 1 to 5 carbon atoms is not particularly limited, but may be, for example, 20 to 90% by weight, preferably 30 to 85% by weight, in total.
[0034] The extract of a Rosaceae Prunus plant is obtained by extracting the above-mentioned plant part to be extracted with the above-mentioned extraction solvent, either directly or, if necessary, by drying, shredding, crushing, squeezing, enzymatically treating, boiling or fermenting the plant part. In particular, in the present invention, it is preferable that the Rosaceae Prunus plant to be subjected to the extraction treatment is subjected to an enzymatic treatment in advance. By using an enzymatically treated Rosaceae Prunus plant as the extraction raw material, it is possible to obtain an extract having a significantly high effect of improving the whitening effect.
[0035] The enzyme used in the enzymatic treatment of the Rosaceae Prunus plant may be a cellulose decomposing enzyme capable of decomposing cellulose in the pulp, specifically, cellulase, hemicellulase, pectinase, etc. These enzymes may be used alone or in combination of two or more.
[0036] The conditions for the enzyme treatment are not particularly limited, and may be set within the range of the active temperature and active pH of the enzyme used, and may be carried out until the enzyme reaction proceeds so as to obtain the desired effect, for example, under conditions of reaction at 20 to 45° C. for 3 to 24 hours. After the enzyme treatment of the Rosaceae family Prunus plant, the enzyme may be inactivated by heating or the like, if necessary, and then the plant may be subjected to a solvent extraction treatment.
[0037] As the solvent extraction treatment, a commonly used method for extracting plant extracts can be used, and specific examples thereof include a soaking method such as cold soaking or hot soaking; a method of stirring under heating; and a percolation method.
[0038] The extract obtained by the solvent extraction treatment may be used in a liquid state as it is, or may be used as a concentrate or a dry product by subjecting it to a treatment such as concentration or drying, if necessary. After concentration or drying, the concentrate or dry product obtained may be purified by washing with a non-dissolving solvent, or may be further dissolved or suspended in a suitable solvent before use.
[0039] In addition, commercially available extracts of plants of the genus Prunus of the family Rosaceae and enzyme-treated extracts of plants of the genus Prunus of the family Rosaceae can be used. For example, an extract of enzymatically decomposed prunes can be "Clairage" manufactured by Ichimaru Pharcos Co., Ltd.
[0040] The content of the component (C) in the topical composition of the present invention may be appropriately determined depending on the formulation form of the topical composition, and may be, for example, 0.00001% by weight or more, specifically 0.00001 to 0.1% by weight, calculated as the dry weight of the component (C). From the viewpoint of further enhancing the effect of improving the whitening effect, the content of the component (C) in the topical composition of the present invention may be The amount is preferably 0.00005 to 0.01% by weight, and more preferably 0.0001 to 0.001% by weight, calculated as the dry weight of the component (C).
[0041] In the topical composition of the present invention, the ratio of component (B) to component (C) is determined according to the respective contents described above. From the viewpoint of achieving an even more excellent whitening effect, the ratio is 1 part by weight or more, preferably 1 to 5,000 parts by weight, more preferably 5 to 500 parts by weight, even more preferably 5 to 100 parts by weight, and particularly preferably 10 to 100 parts by weight, calculated as the dry weight of component (C) per 100 parts by weight (calculated as the dry weight) of component (B).
[0042] (D) a water-soluble thickener, (E) a porous powder, and (F) trimethylglycine. The topical composition of the present invention may contain, in addition to the above-mentioned components, a water-soluble thickener (sometimes referred to as component (D)), a porous powder (sometimes referred to as component (E)), and trimethylglycine (sometimes referred to as component (F)). When the above-mentioned components and the components (D) to (F) are contained together, in addition to an excellent whitening effect, the composition has a firm application feel upon application while being suppressed from being sticky and has a refreshing feel, and after application, the composition is less powdery and can impart an excellent moisturizing feel.
[0043] The water-soluble thickener is not particularly limited as long as it is pharma- ceutically or cosmetically acceptable, and examples thereof include carboxyvinyl polymer, alkyl-modified carboxyvinyl polymer, cellulose gum, xanthan gum, hydroxypropylmethylcellulose, hydroxyethylcellulose, carboxymethylcellulose, (ammonium acryloyldimethyltaurate / VP) copolymer, sodium polyacrylate, carrageenan, xanthan gum, sclerotium gum, polystyrene sulfonate, karaya gum, pectin, etc. Among these, from the viewpoint of more effectively improving the firm application feeling and moisturizing feeling, preferred are carboxyvinyl polymer and alkyl-modified carboxyvinyl polymer.
[0044] Carboxyvinyl polymers are water-soluble vinyl polymers having a carboxyl group, and specifically, are polymers having a crosslinked structure with acrylic acid and / or methacrylic acid as the main chain and with allyl sucrose, allyl ether of pentaerythritol, or the like.
[0045] The alkyl-modified carboxyvinyl polymer is a polymer in which at least a part of the carboxyl group of the carboxyvinyl polymer is esterified with an alkyl group. In the alkyl-modified carboxyvinyl polymer, the alkyl group bonded by the ester bond may be either straight or branched. The number of carbon atoms of the alkyl group is not particularly limited, but may be, for example, 8 to 35, preferably 8 to 30.
[0046] The molecular weight of the carboxyvinyl polymer and the alkyl-modified carboxyvinyl polymer is not particularly limited, but examples thereof include those in which the viscosity of an aqueous solution (pH 6.5) in which the polymer is dissolved to a concentration of 5% by weight at 20° C. is 500 mPa·s or more, and preferably 500 to 100,000 mPa·s. Here, the viscosity is a value measured using a B-type viscometer "TOKI SANGYO VISCOMETER TVB-10" (manufactured by Toki Sangyo Co., Ltd.) with a rotor of M3 (rotation speed: 20 rpm, time: 1 minute, unit: mPa·s).
[0047] These water-soluble thickeners may be used alone or in combination of two or more. From the viewpoint of further improving the above-mentioned feeling of use, it is preferable to use a combination of a carboxyvinyl polymer and an alkyl-modified carboxyvinyl polymer as a water-soluble thickener. When a carboxyvinyl polymer and an alkyl-modified carboxyvinyl polymer are used in combination, the ratio thereof is not particularly limited, but for example, the alkyl-modified carboxyvinyl polymer is 1 to 10,000 parts by weight, preferably 50 to 5,000 parts by weight, and more preferably 10 to 1,000 parts by weight per 100 parts by weight of the carboxyvinyl polymer.
[0048] The water-soluble thickener may be commercially available. For example, commercially available carboxyvinyl polymers include "AQPEC HV-501E" and "AQUP EC HV-505E" manufactured by Sumitomo Seika Chemicals Co., Ltd.; "Carbopol 940", "Carbopol 941", and "Carbopol 980" manufactured by Lubrizol Advanced Materials; "Hiviswaco-103", "Hiviswaco-104", and "Hiviswaco-105" manufactured by Wako Pure Chemical Industries, Ltd.; and "Synthalen K" and "Synthalen L" manufactured by 3V Sigma. Commercially available alkyl-modified carboxyvinyl polymers include "AQUPEC HV-501ER" manufactured by Sumitomo Seika Chemicals Co., Ltd.; "Carpopol ultrez20", "Carbopol ultrez21", "Carbopol 1342", "Carbopol ETD2020", "Pemulen TR-1", and "Pemulen TR-2" manufactured by Lubrizol Advanced Materials.
[0049] The content of component (D) in the topical composition of the present invention may be appropriately set depending on the formulation form of the topical composition, and may be, for example, 0.1 to 3% by weight, preferably 0.3 to 2% by weight, and more preferably 0.3 to 1.5% by weight. By satisfying this content, it becomes possible to more effectively improve the firm application feeling and moisturizing feeling after application due to the interaction with components (E) and (F) described below.
[0050] The porous powder is not particularly limited as long as it is pharma- ceutical or cosmetically acceptable, and examples thereof include inorganic powders such as silica, talc, titanium oxide, mycelium, zinc oxide, kaolin, barium sulfate, bismuth oxychloride, aluminum hydroxide, aluminum silicate, silicic anhydride, silicic acid hydrate, and montmorillonite; and polymer powders such as polyester, polyethylene, polystyrene, methyl methacrylate resin, cellulose, nylon, copolymers of styrene and acrylic acid, polypropylene, and vinyl chloride. These porous powders may be used alone or in combination of two or more.
[0051] Among these porous powders, from the viewpoint of preventing stickiness during application and more effectively improving the refreshing feeling, silica, mica, talc, and nylon are preferable, and silica is more preferable.
[0052] The average particle size of the porous powder is not particularly limited, but may be, for example, 1 to 25 μm, preferably 3 to 20 μm, and more preferably 3 to 15 μm. The oil absorption of the porous powder is not particularly limited, but may be, for example, 50 to 500 ml / 100 g, preferably 50 to 300 ml / 100 g, and more preferably 50 to 200 ml / 100 g. The specific surface area of the porous powder is not particularly limited, but may be, for example, 30 to 1000 m. 2 / g, preferably 100 to 950m 2 / g, more preferably 200 to 800m 2 / g, more preferably 200 to 600m 2 / g. Here, the average particle size of the porous powder is the "arithmetic mean value of particle diameter" defined in JIS Z 8901:2006 "Test powders and test particles". The oil absorption of the porous powder is a value measured in accordance with JIS K5101-13-1. The specific surface area of the porous powder is the BET specific surface area measured in accordance with JIS K6430 Appendix E.
[0053] The content of component (E) in the topical composition of the present invention may be appropriately set depending on the formulation form of the topical composition, etc., and may be, for example, 0.05 to 5 wt. %, preferably 0.5 to 3 wt. %, and more preferably 1 to 3 wt. %.
[0054] Trimethylglycine is found in plants of the Chenopodiaceae family, seaweed, fish, crustaceans, etc., and is a component that is widely used as an amino acid-based moisturizing agent.
[0055] Trimethylglycine may be commercially available. Specific examples of commercially available trimethylglycine include "Aquadew AN-100" manufactured by Ajinomoto Co., Inc. and "Aminocoat" manufactured by Asahi Kasei Chemicals Corporation.
[0056] When the topical composition of the present invention contains the components (D) to (F), the ratio of the components (D) and (F) is preferably 0.1 to 6 parts by weight of the component (F) per 1 part by weight of the component (D). By satisfying such a ratio, it is possible to effectively impart the above-mentioned feeling of use during and after application. From the viewpoint of more effectively imparting the above-mentioned feeling of use during and after application, the ratio of the components (D) and (F) is preferably 1 to 4 parts by weight, more preferably 1.5 to 4 parts by weight, of the component (F) per 1 part by weight of the component (D).
[0057] The content of component (E) in the topical composition of the present invention may be appropriately set so as to satisfy the ratio of components (D) and (F) described above. For example, when the content of component (D) is 0.1 to 3 wt%, the content of component (E) should be 0.01 to 18 wt%, preferably 0.1 to 12 wt%, and more preferably 0.15 to 12 wt%.
[0058] Polyhydric alcohol The topical composition of the present invention may contain a polyhydric alcohol, if necessary, for the purpose of enhancing the moisturizing effect.
[0059] The polyhydric alcohol is not particularly limited as long as it is pharma- ceutically or cosmetically acceptable, and examples thereof include propylene glycol, ethylene glycol, 1,3-butylene glycol, isoprene glycol, diethylene glycol, dipropylene glycol, glycerin, etc. These polyhydric alcohols may be used alone or in combination of two or more. Among these polyhydric alcohols, 1,3-butylene glycol and glycerin are preferred.
[0060] When the topical composition of the present invention contains a polyhydric alcohol, its content may be appropriately set depending on the type of polyhydric alcohol used, the formulation form of the topical composition, etc., and may be, for example, 0.01 to 30% by weight, preferably 0.1 to 20% by weight, and more preferably 1 to 20% by weight.
[0061] water The topical composition of the present invention may contain water as a base, if necessary, to obtain a desired formulation form. In particular, when the above-mentioned components (D) and (F) are contained, it is desirable to contain water as a base for dissolving these components.
[0062] In the topical composition of the present invention, the water content is not particularly limited, but may be, for example, 10 to 99.5% by weight, and preferably 10 to 98% by weight. More specifically, in the case where the composition contains components (D) and (F), the water content may be 25 to 95% by weight, preferably 35 to 95% by weight, and more preferably 45 to 95% by weight.
[0063] Other Ingredients The topical composition of the present invention may contain, in addition to the above-mentioned components, other pharmacological components, if necessary. Examples of such pharmacological ingredients include antihistamines (diphenhydramine, diphenhydramine hydrochloride, chlorpheniramine maleate, etc.), local anesthetics (lidocaine, dibucaine, methyl aminobenzoate, procaine, tetracaine, bupipacaine, mepipacaine, chloroprocaine, proparacaine, meprylcaine or salts thereof, orthocaine, oxethazaine, oxypolyethyleneoxydecane, Scotch extract, percaminpase, tesitdesitin, etc.), anti-inflammatory agents (allantoin, glycyrrhizic acid, methyl glycyrrhizinate, stearyl glycyrrhizinate, dipotassium glycyrrhizinate, monoammonium glycyrrhizinate, glycyrrhetinic acid, pyridoxine glycyrrhetinate, stearyl glycyrrhetinate, glyceryl glycyrrhetinate, glycyrrhetinic acid monoglucuronide, salicylic acid, methyl salicylate, glycol salicylate, indomethacin, felbinac, diclofenac sodium, loxoprofen sodium, ufenamate, ibuprofen piconol, suprofen, bendazac, suprofen, bufexamac, etc.), bactericides (benzalkonium chloride, dequalinium chloride, benzethonium chloride, cetylpyridinium chloride, chlorhexidine chloride, chlorhexidine gluconate, isopropylmethylphenol, aqueous ammonia, sulfadiazine, lactic acid, phenol, etc.), skin protectants (collodion, castor oil, etc.), blood circulation promoters (vanillyl nonyl amide, nicotinic acid benzyl ester, capsaicin, chili pepper extract, etc.), cooling agents (menthol, camphor, etc.), vitamins (vitamins A, B, D, etc.), mucopolysaccharides (sodium chondroitin sulfate, glucosamine, hyaluronic acid, etc.), etc.
[0064] In addition, the topical composition of the present invention may contain a base or additive as necessary to obtain a desired formulation. Such bases and additives are not particularly limited as long as they are pharma- ceutically acceptable, and examples of such bases and additives include aqueous bases such as lower alcohols (ethanol, isopropanol, etc.); oils (olive oil, safflower oil, soybean oil, camellia oil, corn oil, rapeseed oil, sunflower oil, cottonseed oil, peanut oil, lard, squalane, fish oil, etc.), mineral oils (liquid paraffin, paraffin, gelling hydrocarbon, petrolatum, etc.), waxes (beeswax, carnauba wax, candelilla wax, ceresin, rice wax, microcrystalline wax, etc.), ester oils (isopropyl myristate, isopropyl adipate, diethyl sebacate, isopropyl sebacate, isopropyl palmitate, cetyl palmitate, ethyl oleate, glyceryl tri-2-ethylhexanoate, etc.), and the like. oily bases such as fatty acid alkyl esters, fatty acids (stearic acid, oleic acid, palmitic acid, behenic acid, linoleic acid, lanolin, etc.), fatty acid esters (cetyl palmitate, isopropyl palmitate, ethyl linoleate, etc.), medium-chain fatty acid triglycerides, higher alcohols (stearyl alcohol, cetanol, behenyl alcohol, myristyl alcohol, oleyl alcohol, hexadecyl alcohol, lanolin alcohol, cholesterol, dihydrocholesterol, phytosterol, lauryl alcohol, cetostearyl alcohol, linoleyl alcohol, octyldodecanol, hexyldecanol, isostearyl alcohol, etc.), 2-cetyl ethylhexanoate, and silicone oils (dimethylpolysiloxane, cyclic silicone, etc.);Polyoxyethylene alkyl ethers such as POE (10-50 mol) phytosterol ether, POE (10-50 mol) dihydrocholesterol ether, POE (10-50 mol) 2-octyldodecyl ether, POE (10-50 mol) decyltetradecyl ether, POE (10-50 mol) oleyl ether, POE (2-50 mol) cetyl ether, POE (5-50 mol) behenyl ether, POE (5-30 mol) polyoxypropylene (5-30 mol) 2-decyltetradecyl ether, POE (10-50 mol) polyoxypropylene (2-30 mol) cetyl ether, and phosphoric acid salts thereof (e.g., sodium POE cetyl ether phosphate), POE (20-60 mol) sorbitan monooleate, and POE (10-60 mol) sorbitan monoisostearate , POE (10-80 mol) glyceryl monoisostearate, POE (10-30 mol) glyceryl monostearate, POE (20-100 mol)·polyoxypropylene modified silicone, POE·alkyl modified silicone, polyethylene glycol monolaurate, polyethylene glycol monopalmitate, polyethylene glycol monostearate, polyethylene glycol dilaurate, polyethylene glycol dipalmitate, polyethylene glycol distearate, polyethylene glycol dioleate, polyethylene glycol diricinoleate, polyoxyethylene hydrogenated castor oil (5-100), polysorbate (20-85), glycerin fatty acid ester (glycerin monostearate, etc.), hydrogenated soybean phospholipid, hydrogenated lanolin alcohol, and other surfactants;Cooling agents (menthol, camphor, borneol, peppermint water, peppermint oil, etc.), preservatives (methylparaben, propylparaben, benzoic acid, sodium benzoate, sorbic acid, etc.), flavoring agents (citral, 1,8-thioneol, citronellal, farnesol, etc.), coloring agents (tar dyes (brown No. 201, blue No. 201, yellow No. 4, yellow No. 403, etc.), cocoa dyes, chlorophyll, aluminum oxide, etc.), pH adjusters (phosphoric acid, hydrochloric acid, citric acid, sodium citrate, succinic acid, tartaric acid, sodium hydroxide, potassium hydroxide, triethanolamine, triisopropanol, etc.), nolamine, etc.), wetting agents (sodium dl-pyrrolidone carboxylate solution, D-sorbitol solution, macrogol, etc.), stabilizers (dibutylhydroxytoluene, butylhydroxyanisole, sodium edetate, sodium metaphosphate, L-arginine, L-aspartic acid, DL-alanine, glycine, sodium erythorbate, propyl gallate, sodium sulfite, sulfur dioxide, chlorogenic acid, catechin, rosemary extract, etc.), antioxidants, ultraviolet absorbers, chelating agents, adhesives, buffers, dissolution aids, solubilizers, preservatives, and other additives;
[0065] Formulation The topical composition is not particularly limited in its formulation form as long as it is in a form that can be applied transdermally, and may be any of liquid, solid, semi-solid (cream, gel, ointment, paste), etc. The topical composition of the present invention may be a non-emulsified formulation such as an aqueous formulation or an oil-based formulation, or may be an emulsion formulation such as an oil-in-water emulsion formulation or a water-in-oil emulsion formulation.
[0066] From the viewpoint of achieving a more effective whitening effect, the formulation form of the topical composition is preferably a liquid or cream.
[0067] Furthermore, the topical composition may be in any formulation such as a skin topical drug, cosmetic, or skin cleanser, so long as it is applied to the skin.
[0068] Specific examples of the formulation form of the topical composition include liquids (including lotions, sprays, aerosols, and emulsions), water-soluble ointments, oily ointments, creams, foams, gels, and patches; cosmetics such as ointments, creams, emulsions, skin lotions, lotions, packs, and gels; and skin cleansers such as body shampoos, hair shampoos, and rinses. Among these formulation forms, preferred are topical skin medicines, and more preferred are liquids and creams. Preparation into these formulation forms can be carried out by formulating the composition using additives appropriate for the formulation form according to the known methods described in the General Provisions for Preparations of the Japanese Pharmacopoeia, 16th Edition, and the like.
[0069] Purpose The topical composition of the present invention can suppress the production of melanin and can prevent or improve skin blemishes, freckles, dullness, liver spots, senile pigmentation, darkening due to physical stimuli, etc., and is therefore suitable for use as a topical composition for whitening. EXAMPLES
[0070] The present invention will be described in more detail below with reference to examples, but the present invention is not limited to these.
[0071] The manufacturers of the main ingredients used in the following test examples and formulation examples are as follows: L-Ascorbic Acid 2-Glucoside Product name: "AA2G" (manufactured by Hayashibara Co., Ltd.) Magnolia extract Product name: "Falcolex Magnolia B" (manufactured by Ichimaru Falcos Co., Ltd.), liquid, dry solids concentration 0.175% by weight, extract obtained by solvent extraction of Magnolia obovata Thunberg (Magnoliaceae) bark (Japanese magnolia) using an aqueous solution of 1,3-butylene glycol Prune ExtractProduct name: "Cleage" (manufactured by Ichimaru Falcos Co., Ltd.), liquid, dry solids concentration 7.78% by weight, an extract obtained by decomposing the flesh of plums (Prunus domestica Lindl. (Rosaceae)) with cellulose decomposition enzymes, to which water and 1,3-butylene glycol are added. Artichoke Leaf Extract Product name: Biobenefiti (manufactured by Ichimaru Falcos Co., Ltd.), liquid, dry solids concentration 0.08% by weight, an extract obtained by extracting artichoke (Cynara scolymus L. (Compositae)) leaves with an ethanol solution, concentrating and drying the extract, and adding a 1,3-butylene glycol solution to the extract. Geranium extract Product name: "Princess Care" (manufactured by Ichimaru Falcos Co., Ltd.), liquid, dry solids concentration 1% by weight, extract obtained by extracting the whole plant of Geranium robertianum L. (Geraniaceae) with 1,3-butylene glycol solution Alpinia katsumadai seed extract Product name: "Alpinia White" (manufactured by Ichimaru Falcos Co., Ltd.), liquid, dry solid concentration 0.2% by weight, an extract obtained by concentrating an extract obtained by extracting the seeds of Alpinia katsumadai Hayata (Zingiberaceae) with an ethanol solution and adding a 1,3-butylene glycol solution Chinpi extract Product name: "Mandarin Clear" (manufactured by Ichimaru Falcos Co., Ltd.), liquid, dry solids concentration 3% by weight, extract obtained by extracting the ripe peel of mandarin orange (Citrus reticulate Blanco (Rutaceae)) with 1,3-butylene glycol solution Bilberry Leaf Extract Product name: Cureberry (manufactured by Ichimaru Falcos Co., Ltd.), liquid, dry solids concentration 0.2% by weight, extract obtained by extracting bilberry (Vaccinium myrtillus L. (Ericaceae)) leaves with 1,3-butylene glycol solution Carboxyvinyl PolymerProduct name: Carbopol 980 (manufactured by Lubrizol Advanced Materials) Alkyl-modified carboxyvinyl polymer Product name: Carbopol Ultrez 20 (manufactured by Lubrizol Advanced Materials, number of carbon atoms in alkyl group: 10 to 30) silica Product name: God Ball D-25C (manufactured by Suzuki Oil Industries Co., Ltd.), average particle size 7-10 μm, specific surface area 300-500 m 2 / g, oil absorption 70~110ml / 100g
[0072] Test Example 1: Evaluation of melanin production inhibition effect The melanin production inhibitory effect was evaluated using a three-dimensional cultured skin model (MEL-300-A, MatTek). The specific test method is as follows.
[0073] The MEL-300 skin model cup was placed in each well of a 6-well plate containing 0.9 ml of maintenance medium (EPI-100LLMM) warmed to 37°C, and left in an incubator (37°C, 5% CO2) for 1 hour. Next, 50 μl of each sample solution (pH 6.5) with the composition shown in Tables 1 and 2 was added to the inside of the skin model cup, and cultured for 24 hours in an incubator (37°C, 5% CO2). After that, ultraviolet light (UV-B) was irradiated at 0.5 mW x 12 seconds per time, and the cells were further cultured for 24 hours. The ultraviolet light irradiation was performed using a UVB lamp (Toshiba Lighting & Technology Corporation, Toshiba Health Line Fluorescent Lamp) and a UV detector (TOPCON, UV-1). After that, the medium was replaced and the cells were further cultured for 24 hours. Each time the medium was replaced, 50 μl of the specified sample solution was added to the skin model cup. Furthermore, by repeating UV irradiation and medium exchange under the same conditions four times, UV irradiation was repeated five times in total (total UV irradiation dose 30 mJ / cm 2 ), and the medium was replaced a total of five times. After that, the cell viability and melanin production were measured by the methods described below. As a control, an aqueous solution containing 0.5% by weight of 1,3-butylene glycol was used as the sample solution, and the test was carried out under the same conditions as above.
[0074] <Measurement of cell activity> The cell viability was measured by the MTT test. Specifically, 0.75 ml of the MTT test drug and 8.25 ml of maintenance medium (EPI-100LLMM) were mixed and added to each well so that the volume was 300 μl. The skin model cup was transferred to the medium containing the MTT prepared above and cultured in an incubator for exactly 3 hours. The bottom of the tissue was then lightly washed with PBS washing solution and transferred to a new plate. 1 ml of 0.04 N HCl acidic isopropanol was added to the inside of the skin model cup, and blue formazan was extracted overnight in an incubator with a cover seal attached to the plate to prevent evaporation and to protect it from light. After extraction, the isopropanol was mixed well and 200 μl of it was transferred to a 96-well plate. The optical density at 570 nm and 620 nm was measured using a microplate reader, and the difference between them was used as the cell activity.
[0075] <Measurement of melanin production> After washing the MEL-300 skin model cup with PBS, the cell tissue was peeled off with a scalpel and collected. The obtained cell tissue was immersed in PBS, crushed and centrifuged (2,000 rpm, 10 min). The supernatant was then removed, and a mixture of ethanol and dimethyl ether (ethanol: dimethyl ether = 3: 1 (volume ratio)) was added, followed by stirring and centrifugation (2,000 rpm, 10 min). The supernatant was then removed and the tissue was dried. A 1N aqueous solution of sodium hydroxide (containing 10% by weight DMSO) was added to the dried product, which was then treated in a water bath at 90°C for 20 minutes to be heated and melted. The heated and melted solution was then lightly stirred with a vortex and cooled to room temperature, after which the absorbance at 405 nm was measured to determine the amount of melanin produced.
[0076] The amount of melanin produced per cell was calculated by dividing the amount of melanin produced by the cell viability. Furthermore, the ratio of the amount of melanin produced per cell when each sample solution was added (melanin production ratio) was calculated, taking the amount of melanin produced per cell in the control as 100.
[0077] The results are shown in Tables 1 and 2. As a result, no melanin production inhibitory effect was observed when Magnolia obtusifolia extract was used alone (Comparative Example 2), and the melanin production inhibitory effect was insufficient when ascorbic acid 2-glucoside was used alone (Comparative Example 1). Furthermore, even when ascorbic acid 2-glucoside was combined with plant extracts known to have melanin production inhibitory effects (prune extract, Chinese citrus fruit extract, artichoke leaf extract, bilberry leaf extract, Alpinia quinata seed extract, and Geranium phillyraeoides extract) (Comparative Examples 3 to 8), almost no enhancement of the melanin production inhibitory effect was observed.
[0078] In contrast, when ascorbic acid 2-glucoside was combined with the Magnolia obtusa extract (Example 1 and 3 -11) showed a significantly improved melanin production inhibitory effect. Furthermore, when prune extract was combined with ascorbic acid 2-glucoside and Magnolia obovata extract (Examples 4-8), a dramatic improvement in melanin production inhibitory effect was observed. On the other hand, even when other plant extracts known to have melanin production inhibitory effects (artichoke leaf extract, Geranium globulus extract, Alpinia quinquefolia seed extract) were combined with ascorbic acid 2-glucoside and Magnolia obovata extract, the melanin production inhibitory effect was not as improved as in the case of prune extract.
[0079] [Table 1]
[0080] [Table 2]
[0081] Test Example 2: Evaluation of Usability Skin cosmetics (liquids) having the compositions shown in Tables 3 and 4 were prepared. Specifically, the manufacturing procedure is as follows. After stirring and dissolving a carboxyvinyl polymer and an alkyl-modified carboxyvinyl polymer in purified water, glycerin was added and stirred and dissolved to obtain Preparation A. Separately, trimethylglycine and / or silica were added to 1,3-butylene glycol, and the mixture was stirred and mixed to homogenize to obtain Preparation B. Next, Preparation B was added while stirring Preparation A, and the mixture was stirred and homogenized with a homomixer. Furthermore, potassium hydroxide was added to adjust the pH to 6.5, and then L-ascorbic acid 2-glucoside, Magnolia obovata extract, and prune extract were added and stirred to homogenize to prepare a skin cosmetic.
[0082] Each of the obtained skin cosmetics was evaluated by the following methods with respect to a firm application feel, a non-sticky feeling and a refreshing feeling upon application, and a non-powdery feeling and a warm feeling after application.
[0083] Ten evaluation monitors applied approximately 0.5g of each skin cosmetic to their arms and evaluated the firm application feeling, non-sticky feeling and refreshing feeling when applying, and the lack of powderiness and moisturizing feeling after application. Specifically, the evaluation was scored by conducting a questionnaire using a visual analogue scale (hereinafter sometimes referred to as VAS) with the following as "1" and "10". The evaluation results were summarized by averaging the questionnaire results and rounding off to the nearest tenth. <When applying> Application feel No sticky feeling when applied / No feeling of crushing the gel when applied "1" "10": Feels like a sticky coating / like a gel being crushed · Refreshing Not refreshing "1" A refreshing feeling "10" -No sticky feeling Sticky feeling "1" Doesn't feel sticky "10" <30 seconds after application> -Lack of powderiness Powdery feeling "1" Not powdery "10" Moisturizing feeling No moisturizing feeling (moisturizing feeling) "1" "l0" has a moisturizing (moisturizing) feel
[0084] The results are shown in Tables 3 and 4. When the composition contained a water-soluble thickener (carboxyvinyl polymer, alkyl-modified carboxyvinyl polymer), silica, and trimethylglycine in addition to ascorbic acid 2-glucoside, Magnolia obisaki extract, and prune extract, the results were satisfactory in terms of firm application feel, non-stickiness, refreshing feeling, non-powdery, and moisturizing feeling. In particular, when the amount of trimethylglycine was 0.1 to 6 parts by weight per part by weight of the water-soluble thickener, the results were extremely good in terms of firm application feel, non-stickiness, refreshing feeling, non-powdery, and moisturizing feeling.
[0085] [Table 3]
[0086] [Table 4]
[0087] Prescription Examples 1-9 According to the formulations shown in Table 5, skin cosmetics were prepared in a conventional manner (Formulation Examples 1 to 6 had a pH of 6.5, and Formulation Examples 7 to 9 had a pH of 4.5).
[0088] [Table 5]
[0089] Prescription Examples 10-15 According to the formulations shown in Table 6, skin cosmetics were prepared in the following manner. Step (1): L-ascorbic acid 2-glucoside or L-ascorbyl magnesium phosphate was dissolved in purified water, and the pH was then adjusted to 6 with a solution of potassium hydroxide dissolved in purified water (Preparation (A-1)). Step (2): (B) and (C) were dissolved by heating and stirring, respectively (Preparation (B) and Preparation (C)). Step (3): Preparation (C) was added to Preparation (B) while heating and stirring, and the mixture was stirred and homogenized using a homomixer. Step (4): The mixture was then gradually cooled to 40° C. or below while stirring, and the remaining components (A-1) and (A) were added thereto, followed by stirring to homogenize to prepare a skin cosmetic.
[0090] [Table 6]
Claims
1. A composition for external use (excluding those containing 2-amino-2-hydroxymethyl-1,3-propanediol and ethylenediaminetetraacetic acid or a salt thereof), characterized by containing (A) 0.1 to 10% by weight of ascorbic acid and / or its derivatives, (B) an extract of Magnolia obovata, and (C) an extract of prune pulp.
2. The composition for external use according to claim 1, wherein the component (A) is ascorbic acid 2-glucoside.
3. The composition for external use according to claim 1 or 2, which is for whitening.
4. A method for improving the melanin production inhibitory effect of an externally applied composition containing (A) 0.1 to 10% by weight of ascorbic acid and / or a derivative thereof, and (B) an extract of Magnolia obtusifolia (excluding those containing 2-amino-2-hydroxymethyl-1,3-propanediol and ethylenediaminetetraacetic acid or a salt thereof), comprising: The method, wherein the topical composition contains (C) an extract of prune pulp.
Citation Information
Patent Citations
Beautifying cosmetic
JP1992082814A
Antiinflammable agent
JP1998109941A
Collagenase activity inhibitor
JP2003146876A
Composition for external use
JP2006008710A
Phagocytosis inhibitor
JP2006124355A
